N/A
N=37
Use of Amplification in Children With Unilateral Hearing Loss
Unilateral Hearing Loss
Bottom Line
View on ClinicalTrials.gov: NCT02269124 ↗Enrolled (actual)
37
Serious AEs
—
Results posted
Aug 2021
Primary outcome: Primary: HEAR-QL 26 Questionnaire — 69.61; 74.05; 71.04; 80.21 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Hearing aid (Device)
- Age
- Pediatric · 6+ yrs
- Sex
- All
- Sponsor
- Massachusetts Eye and Ear Infirmary
- Primary completion
- Mar 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HEAR-QL 26 Questionnaire |
69.61; 74.05; 71.04; 80.21; 74.31; 87.15 | — |
| PRIMARY CHILD (Child) Questionnaires |
69.21; 72.83; 75.23; 82.83; 77.59; 80.13 | — |
| PRIMARY LIFE-R Student Questionnaires |
58.83; 67.05; 62.81; 77.05; 64.78; 80.37 | — |
| SECONDARY LIFE-R Teacher |
68.69; 83.55; 73.66; 90.61; 74.26; 89.77 | — |
| SECONDARY CHILD (Parent) Questionnaire |
68.52; 73.40; 67.24; 81.81; 72.77; 81.73 | — |
Summary
Unilateral hearing loss (UHL) in children has been demonstrated to have a negative impact on quality of life, school performance and behavior. Despite this knowledge, it remains unclear how to best manage this common problem. There has been much debate regarding this issue with many programs recommending preferential seating in the classroom and use of a frequency-modulated (FM) system to amplify the teacher's voice in the classroom (conventional measures), and others recommending these accommodations in addition to use of a hearing aid for amplification (amplification). There is very limited research to support or refute the efficacy of a hearing aid in improving measurable academic, behavioral, or quality-of-life (QOL) outcomes in children with UHL. We propose a study evaluating the impact of hearing aid use in school-aged children (ages 6-12 years) with mild to moderately severe UHL. In this study, subjects will be randomized to receive either conventional measures or conventional measures plus amplification. After a three month period, the groups will be reversed, with each subject serving as their own control. Outcome measurements will include patient reported disease-specific QOL reported by patients, parents, and teachers using validated survey instruments at regular intervals throughout the study period.
Eligibility Criteria
Inclusion Criteria
Children ages 6-12 years with mild to moderately severe unilateral hearing loss, with thresholds across 4 frequencies ≥ 25 dB but < 70 dB in the worse hearing ear; Normal hearing in the contralateral ear, defined as thresholds ≤ 20 dB from 250 Hz to 8000 Hz; Unaided word recognition scores of ≥ 80% in worse hearing ear
Exclusion Criteria
Contralateral hearing loss; Significant cognitive impairment; Middle ear disease that has not been addressed; Inability to commit to treatment program
Data sourced from ClinicalTrials.gov (NCT02269124). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.